NCT01358045View on ClinicalTrials.gov

Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

May 31, 2013

Conditions
Basal Cell Carcinoma
Interventions
DRUG

Diclofenac

Application on the lesion 2 times a day 8 weeks.

DRUG

Diclofenac + Calcitriol

Application on the lesion 2 times a day, both ointments, 8 weeks.

DRUG

Calcitriol

Application on the lesion, 2 times a day, 8 weeks.

Trial Locations (1)

6202 AZ

Maastricht University Medical Center, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT01358045 - Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma | Biotech Hunter | Biotech Hunter